Advances on the treatment of Fusobacterium nucleatum-promoted colorectal cancers using nanomaterials.
- Author:
Hang WANG
1
;
Xiaoxue HOU
1
;
Jianfeng LIU
1
;
Cuihong YANG
1
Author Information
- Publication Type:Journal Article
- Keywords: Fusobacterium nucleatum (Fn); cancer therapy; colorectal cancer; nanomaterials
- MeSH: Humans; Colorectal Neoplasms/pathology*; Fusobacterium nucleatum/genetics*; Base Composition; RNA, Ribosomal, 16S; Phylogeny; Sequence Analysis, DNA; Tumor Microenvironment
- From: Chinese Journal of Biotechnology 2023;39(9):3670-3680
- CountryChina
- Language:Chinese
- Abstract: Fusobacterium nucleatum (Fn) is an oral anaerobic bacterium that has recently been found to colonize on the surface of colorectal cancer cells in humans, and its degree of enrichment is highly negatively correlated with the prognosis of tumor treatment. Numerous studies have shown that Fn is involved in the occurrence and development of colorectal cancer (CRC), and Fn interacts with multiple components in the tumor microenvironment to increase tumor resistance. In recent years, researchers have begun using nanomedicine to inhibit Fn's proliferation at the tumor site or directly target Fn to treat CRC. This review summarizes the mechanism of Fn in promoting CRC and the latest research progress on Fn-related CRC therapy using different nanomaterials. Finally, the applications perspective of nanomaterials in Fn-promoted CRC therapy was prospected.
